drugset / Trial / NCT01322438
Effect of Rifampin on the Pharmacokinetics of BAY73-4506
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to see if giving rifampin, a marketed antibiotic, changes how your body absorbs and distributes BAY73-4506.
Timeline
- Start
- 2011-03
- Primary completion
- 2011-06
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Regorafenib | Small molecule | 160 mg | Oral |
| Subject | Rifampin | Small molecule | 600 mg | Oral |